BioSpace News Archive

Troy-based Jagannathan Neurosurgery is pleased to announce the addition of it’s second board-certified neurosurgeon, Dr. M. Adam Kremer.

AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) wishes to amend its news release dated July 2, 2020 in which it announced a shares for debt transaction.

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for a COVID-19 antigen diagnostic test, the BD ( Becton Dickinson ) Veritor System for Rapid Detection of SARS-CoV-2. This is the second antigen test the FDA has authorized for the detection of SARS-CoV-2 antigens. This test is authorized for use in l

The Industrial Macromolecular Crystallography Association, an association of pharmaceutical companies that leverages the power of high-energy X-rays to accelerate structural biology research for drug discovery, announced that Janssen Research & Development, LLC has joined IMCA.

The infectious disease has become prevalent in tropical and sub-tropical countries.

Agricor Laboratories and Botanacor Laboratories jointly announced that Carl Craig has assumed the role of CEO of both companies. He had been the companies’ COO.

The World Health Organization reports AIDS drug stock outs in two dozen countries, which threaten access to lifesaving medicines for some 8.3 million people; an additional 73 countries warn WHO they are at risk of their own stocks running out

Marrone Bio Innovations, Inc., (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to global agricultural needs, today announced the appointment of Kevin Helash as its new chief executive officer

Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report second quarter 2020 financial results on Thursday, August 6, 2020, after the close of the market.

Otonomy, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, provided an update on the statistical analysis plan related to the ongoing Phase 3 clinical trial of OTIVIDEX in Ménière’s disease.